AU2000273085A1 - Sustained release pharmaceutical compositions containing metformin and method ofits production - Google Patents

Sustained release pharmaceutical compositions containing metformin and method ofits production

Info

Publication number
AU2000273085A1
AU2000273085A1 AU2000273085A AU7308500A AU2000273085A1 AU 2000273085 A1 AU2000273085 A1 AU 2000273085A1 AU 2000273085 A AU2000273085 A AU 2000273085A AU 7308500 A AU7308500 A AU 7308500A AU 2000273085 A1 AU2000273085 A1 AU 2000273085A1
Authority
AU
Australia
Prior art keywords
production
pharmaceutical compositions
sustained release
compositions containing
release pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2000273085A
Inventor
Suresh Kumar Gidwani
Purushottam Singnurkar
Prashant Kumar Tewari
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
USV Pvt Ltd
Original Assignee
USV Pvt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by USV Pvt Ltd filed Critical USV Pvt Ltd
Publication of AU2000273085A1 publication Critical patent/AU2000273085A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
AU2000273085A 2000-10-02 2000-10-02 Sustained release pharmaceutical compositions containing metformin and method ofits production Abandoned AU2000273085A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB2000/001404 WO2002028181A1 (en) 2000-10-02 2000-10-02 Sustained release pharmaceutical compositions containing metformin and method of its production

Publications (1)

Publication Number Publication Date
AU2000273085A1 true AU2000273085A1 (en) 2002-04-15

Family

ID=11003976

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2000273085A Abandoned AU2000273085A1 (en) 2000-10-02 2000-10-02 Sustained release pharmaceutical compositions containing metformin and method ofits production

Country Status (9)

Country Link
US (1) US20110195120A2 (en)
EP (1) EP1322158B1 (en)
JP (1) JP2004510716A (en)
KR (1) KR100713234B1 (en)
AU (1) AU2000273085A1 (en)
DK (1) DK1322158T3 (en)
ES (1) ES2392705T3 (en)
PT (1) PT1322158E (en)
WO (1) WO2002028181A1 (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003004009A1 (en) * 2001-07-02 2003-01-16 Geneva Pharmaceuticals, Inc. Pharmaceutical composition
EP1465612A1 (en) * 2001-11-06 2004-10-13 Ranbaxy Laboratories Limited Controlled release tablets of metformin
EP1515701B1 (en) 2002-06-17 2014-09-17 Inventia Healthcare Private Limited Process for the manufacture of multilayer tablet compositions comprising thiazolidinedione and biguanide
US8084058B2 (en) 2002-09-20 2011-12-27 Watson Pharmaceuticals, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US7785627B2 (en) 2002-09-20 2010-08-31 Watson Pharmaceuticals, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US7959946B2 (en) 2002-09-20 2011-06-14 Watson Pharmaceuticals, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US9060941B2 (en) 2002-09-20 2015-06-23 Actavis, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US20040086566A1 (en) * 2002-11-04 2004-05-06 Alpharma, Inc. Waxy matrix dosage forms
US20060153915A1 (en) 2003-01-23 2006-07-13 Amorepacific Corporation Sustained-release preparations and method for producing the same
WO2004110422A1 (en) * 2003-06-16 2004-12-23 Ranbaxy Laboratories Limited Extended-release tablets of metformin
US20080181946A1 (en) * 2004-05-14 2008-07-31 Braj Bhushan Lohray Controlled Release Delivery System For Metformin
CN102429882B (en) 2004-11-04 2015-03-25 什诺波特有限公司 Gabapentin prodrug sustained release oral dosage forms
MX2007014041A (en) * 2005-05-10 2008-02-11 Novartis Ag Extrusion process for making compositions with poorly compressible therapeutic compounds.
CN101166517B (en) * 2005-05-10 2012-01-04 诺瓦提斯公司 Extrusion process for making compositions with poorly compressible therapeutic compounds
KR100780553B1 (en) * 2005-08-18 2007-11-29 한올제약주식회사 Pharmaceutical compositions and formulations of Metformin extended release tablets and its preparing method
KR100858848B1 (en) * 2006-05-23 2008-09-17 한올제약주식회사 Pharmaceutical compositions and formulations of Metformin extended release tablets
US20100221335A1 (en) * 2007-08-31 2010-09-02 Daiichi Sankyo Company, Limited Sustained-release preparation and method for producing the same
DE102012102414A1 (en) 2012-03-21 2013-10-10 Michael Dittgen Composition, used to treat diabetes mellitus, includes antidiabetic drug as active substance, preferably metformin or its salt, where the composition is divided into two compartments, which include drug and three groups of adjuvants
CN104922091B (en) * 2015-07-15 2017-12-26 山东司邦得制药有限公司 A kind of diabecron sustained-release capsule and its preparation method and application
CN107519147B (en) * 2016-06-21 2021-12-21 广州医药研究总院有限公司 Desvenlafaxine sustained-release pellet and preparation method thereof
CN111450069A (en) * 2020-04-02 2020-07-28 南京致中生物科技有限公司 Metformin hydrochloride oral sustained-release tablet and preparation method thereof

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6056122B2 (en) * 1980-05-21 1985-12-09 塩野義製薬株式会社 sustained release formulation
JP2681373B2 (en) * 1988-07-18 1997-11-26 塩野義製薬株式会社 Method for manufacturing sustained-release preparation
SE9200858L (en) * 1992-03-20 1993-09-21 Kabi Pharmacia Ab Method for producing delayed release pellets
US5705483A (en) * 1993-12-09 1998-01-06 Eli Lilly And Company Glucagon-like insulinotropic peptides, compositions and methods
ATE178789T1 (en) * 1994-02-21 1999-04-15 Takeda Chemical Industries Ltd POLYESTER MATRIX FOR A DELAYED RELEASE PHARMACEUTICAL COMPOSITION
DE4432757A1 (en) * 1994-09-14 1996-03-21 Boehringer Mannheim Gmbh Pharmaceutical preparation containing metformin and process for its preparation
IT1276130B1 (en) * 1995-11-14 1997-10-27 Gentili Ist Spa GLIBENCLAMIDE-METFORMIN ASSOCIATION, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT AND THEIR USE IN THE TREATMENT OF TYPE DIABETES MELLITUS
FR2745500B1 (en) * 1996-03-04 1998-04-03 Synthelabo SUSTAINED RELEASE PHARMACEUTICAL FORMULATIONS CONTAINING MIZOLASTINE
US6011049A (en) * 1997-02-19 2000-01-04 Warner-Lambert Company Combinations for diabetes
ES2248908T7 (en) * 1997-06-06 2014-11-24 Depomed, Inc. Dosage forms of drugs orally and gastric retention for continued release of highly soluble drugs
ATE261935T1 (en) * 1997-12-08 2004-04-15 Bristol Myers Squibb Co NEW METFORMIN SALTS AND METHODS
BR9908911A (en) * 1998-03-19 2001-10-02 Bristol Myers Squibb Co Biphasic system and distribution process by controlled release of high solubility pharmaceutical substances
US6099859A (en) * 1998-03-20 2000-08-08 Andrx Pharmaceuticals, Inc. Controlled release oral tablet having a unitary core
US6197340B1 (en) * 1998-05-28 2001-03-06 Medical Research Institute Controlled release lipoic acid
US6117451A (en) * 1998-08-25 2000-09-12 Pharmalogix, Inc. Direct compression metformin hydrochloride tablets
US6099862A (en) * 1998-08-31 2000-08-08 Andrx Corporation Oral dosage form for the controlled release of a biguanide and sulfonylurea
AU1881600A (en) * 1998-12-23 2000-07-31 Alza Corporation Dosage forms comprising porous particles
US6936275B2 (en) * 1999-12-20 2005-08-30 Scolr, Inc. Amino acid modulated extended release dosage form
BR0016705A (en) * 1999-12-22 2002-09-24 Pharmacia Corp Dual-release compositions of a cyclooxygenase-2 inhibitor
US6676966B1 (en) * 2000-05-09 2004-01-13 Intellipharmaceutics Corp. Extended release metformin hydrochloride formulations
US6488962B1 (en) * 2000-06-20 2002-12-03 Depomed, Inc. Tablet shapes to enhance gastric retention of swellable controlled-release oral dosage forms
WO2003004009A1 (en) * 2001-07-02 2003-01-16 Geneva Pharmaceuticals, Inc. Pharmaceutical composition
US20030118647A1 (en) * 2001-12-04 2003-06-26 Pawan Seth Extended release tablet of metformin
WO2003099214A2 (en) * 2002-05-23 2003-12-04 Andrx Corporation Biguanide formulations
US20050065062A1 (en) * 2003-09-24 2005-03-24 3M Innovative Properties Company Method of formulating a pharmaceutical composition
US20060062846A1 (en) * 2004-09-17 2006-03-23 Cimex Pharma Ag Alfuzosin tablets and synthesis

Also Published As

Publication number Publication date
PT1322158E (en) 2012-11-23
EP1322158B1 (en) 2012-08-08
KR100713234B1 (en) 2007-05-02
ES2392705T3 (en) 2012-12-13
US20110195120A2 (en) 2011-08-11
JP2004510716A (en) 2004-04-08
WO2002028181A1 (en) 2002-04-11
EP1322158A1 (en) 2003-07-02
EP1322158A4 (en) 2005-11-23
DK1322158T3 (en) 2012-11-19
US20040076667A1 (en) 2004-04-22
KR20030036877A (en) 2003-05-09

Similar Documents

Publication Publication Date Title
AU2000273085A1 (en) Sustained release pharmaceutical compositions containing metformin and method ofits production
AU781269C (en) Pharmaceutical compositions
AU2002248377A1 (en) A controlled release pharmaceutical composition
AU2001250420A1 (en) Pharmaceutical compositions
AU2002229140A1 (en) Controlled release pharmaceutical composition
AU2001274307A1 (en) Pharmaceutical compositions
AU2003291103A1 (en) Pharmaceutical composition
AU2002337803A1 (en) Sustained release pharmaceutical compositions
AUPR602501A0 (en) Sustained release pharmaceutical composition
AU2002302147A1 (en) Pharmaceutical composition
AU2003260803A1 (en) Sustained release pharmaceutical composition
AU2003250372A1 (en) Pharmaceutical composition
AU2002258221A1 (en) Medicinal composition
AU2001290239A1 (en) Medicinal composition
AU2001248772A1 (en) Sustained release drug compositions
AU2001273919A1 (en) Pharmaceutical compositions
EP1478353A4 (en) Sustained release pharmaceutical composition
AU5249401A (en) Sustained release pharmaceutical composition containing glipizide and method forproducing same
AU4085201A (en) Pharmaceutical composition
AU2003284460A1 (en) Medicinal composition
AU2003280799A1 (en) Medicinal composition
AU2002354460A1 (en) Medicinal composition
AU3586401A (en) Pharmaceutical composition
AU2001278705A1 (en) Pharmaceutical composition
AUPR529701A0 (en) Pharmaceutical composition